In early 2025, we made four top-of-mind calls, along with potential implications for Patient Support1: policy volatility would test access; macro pressure would demand measurable efficiency; AI would become platform-level; and pricing/staffing would begin to shift. This report card scores those calls against what actually happened, confirming where momentum is real, where it’s early, and what to do next. Reference the grades as a quick read on traction and as a filter for 2026 plans.
How to interpret
- Each prediction includes a grade, a one-line verdict, up to three proof bullets, and a short evidence note.
- Grades: A = realized; B = mostly true with caveats; C = mixed/uneven; D = largely missed.
The Bottom Line
During 2025, access/adherence held center, efficiency became mandatory, and AI moved from pilot to platform. Pricing and staffing shifts are emerging but uneven, so IQVIA recommends governing to outcomes while you scale automation and preserve high-touch moments. Treat these grades as a 2026 checklist: cut time-to-resolution, improve first call resolution, and anchor partners on results – not FTEs.
IQVIA Patient Support Services is enthusiastic about the importance of programs that help people start and stay on life-changing and life-saving therapies. We believe prioritizing efficiency in program design and execution will continue to be important as economic pressures heighten in 2026.
Reference:
Keeping Patients on Therapy
IQVIA Patient Support Services is enthusiastic about the importance of programs that help people start and stay on life-changing and life-saving therapies. We invite you to reach out to explore how IQVIA could help your program.